openPR Logo
Press release

Investigation for Long-Term Investors in shares of PharmaCielo Ltd. (OTC: PCLOF) announced

05-27-2020 12:45 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in PharmaCielo Ltd. (OTC: PCLOF) shares.

An investigation on behalf of current long term investors in PharmaCielo Ltd. (OTC: PCLOF) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of PharmaCielo Ltd..

Investors who are current long term investors in PharmaCielo Ltd. (OTC: PCLOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in OTC: PCLOF stocks follows a lawsuit filed against PharmaCielo Ltd. over alleged securities laws violations. The investigation on behalf of current long term investors in OTC: PCLOF stocks, concerns whether certain PharmaCielo directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that PharmaCielo engaged in an undisclosed related party transactions with General Extract LLC, that PharmaCielo engaged in misleading transactions and loans with General Extract LLC and XPhyto Therapeutics Corp., that PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed, that the Rionegro facility is located on a floodplain and contaminated with mold and pesticides from its previous tenants, that PharmaCielo's Cauca Department land has never been utilized by the Company and is idle, and that as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Those who purchased shares of PharmaCielo Ltd. (OTC: PCLOF) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Long-Term Investors in shares of PharmaCielo Ltd. (OTC: PCLOF) announced here

News-ID: 2058534 • Views: 388

More Releases from Shareholders Foundation

Investigation for Long-Term investors in NASDAQ: KNDI shares over possible Wrong …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Kandi Technologies Group Inc. Investors who are current long term investors in Kandi Technologies Group Inc (NASDAQ: KNDI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: KNDI stocks follows a lawsuit filed
Investigation for Long-Term Investors in shares of Kirby Corporation (NYSE: KEX) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Kirby Corporation. Investors who purchased shares of Kirby Corporation (NYSE: KEX) s have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Kirby Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders. Houston, TX based
Investigation announced for Investors in shares of Builders FirstSource, Inc. (N …
An investigation was announced concerning whether the takeover of Builders FirstSource, Inc. is unfair to NASDAQ: BLDR stockholders. Investors who purchased shares of Builders FirstSource, Inc. (NASDAQ: BLDR) and currently hold any of those NASDAQ: BLDR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Builders FirstSource, Inc. breached their
Investigation for Investors in ANSDAQ: ENDP over possible Wrongdoing at Endo Int …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Endo International plc. Investors who are current long term investors in Endo International plc (NASDAQ: ENDP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: ENDP stocks follows a lawsuit filed against Endo

All 5 Releases


More Releases for PharmaCielo

Deadline in Lawsuit on May 5th coming up for Investors in PharmaCielo Ltd. (OTC: …
A deadline is coming up on May 5, 2020 in the lawsuit filed for certain investors of PharmaCielo Ltd. (OTC: PCLOF) over alleged securities laws violations by PharmaCielo Ltd. Investors who purchased shares of PharmaCielo Ltd. (OTC: PCLOF) have certain options and there are strict and short deadlines running. Deadline: HHHHH. OTC: PCLOF stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the complaint filed